IP Library › Granted Patent US 10,206,974
Granted Patent B2
US 10,206,974 · App. 15/397,359 · Granted Feb 19, 2019

Antimicrobial compositions and method of use thereof

Inventors: Vincent Craig Bond (Stone Mountain, GA); Michael Powell (Douglasville, GA); Ming Bo Huang (Atlanta, GA); Syed Ali (New Iberia, LA); Martin Neville Shelton (Seattle, WA)
Assignee: MOREHOUSE SCHOOL OF MEDICINE
A61K38/162A61K38/08A61K45/06A61K47/60C07K7/06C12N7/00C12N2740/16032Y02A50/401Y02A50/471Y02A50/473Y02A50/475Y02A50/478Y02A50/481
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,206,974
App. No.
15/397,359
Granted
Feb 19, 2019
Kind
B2
Abstract

The present application discloses a method for treating microbial infection using an antimicrobial composition comprises antimicrobial peptide which contains at least one VGFPV motif.

Claims (15)

1. A method of treating a gram negative microbial infection, comprising:

administering to a subject in need thereof an effective amount of an antimicrobial peptide comprising:

the amino acid sequence of VGFPVAAVGFPV (SEQ ID NO: 3);

one of more targeting domains; and

an Fc region, wherein the Fc region is linked to the one or more targeting domains.

2. The method of claim 1 , wherein said antimicrobial peptide has a length of 12-20 amino acids.

3. The method of claim 1 , wherein the one or more targeting domains of said antimicrobial peptide comprises an epitope binding domain.

4. The method of claim 1 , wherein said antimicrobial peptide comprises at least one VGFPV motif at the N-terminal.

5. The method of claim 1 , wherein said antimicrobial peptide comprises at least one VGFPV motif at the C-terminal.

6. The method of claim 1 , wherein said antimicrobial peptide further comprises a second antimicrobial domain, wherein said second antimicrobial domain is different for said first antimicrobial domain.

7. The method of claim 1 , wherein said antimicrobial peptide further comprises a cell penetrating peptide (CPP) domain.

8. The method of claim 1 , wherein said antimicrobial peptide is administered in combination with another antimicrobial agent.

9. The method of claim 8 , wherein said another antimicrobial agent is another antimicrobial peptide.

10. The method of claim 8 , wherein said another antimicrobial agent is an in vivo expression vector encoding said antimicrobial peptide.

11. The method of claim 8 , wherein said antimicrobial peptide is a PEGylated peptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2018
From: BOND, VINCENT C.; POWELL, MICHAEL; HUANG, MING BO; ALI, SYED; SHELTON, MARTIN NEVILLE
To: MOREHOUSE SCHOOL OF MEDICINE
Reel/Frame 045131/0520 →
Continuity (3)
Continuation 14156119 · Jan 15, 2014
Continuation 13267977 · Oct 7, 2011
Related Publication 20170209533A1 · Jul 27, 2017
Cited By (2)
US 12,187,767 US 12,303,546